NEUROPROTECTIVE AMYLOID Β N-TERMINAL PEPTIDES DIFFERENTIALLY ALTER HUMAN Α7- AND Α7Β2-NICOTINIC ACETYLCHOLINE (NACH) RECEPTOR SINGLE-CHANNEL PROPERTIES
Main Article Content
Keywords
iso-form, receptors, amyloid beta peptides
Abstract
Oligomeric amyloid β 1-42 (oAβ1-42) exhibits agonist-like action at human α7- and α7β2-containing nicotinic receptors. The N-terminal amyloid β1-15 fragment (N-Aβ fragment) modulates presynaptic calcium and enhances hippocampal-based synaptic plasticity via α7-containing nicotinic receptors. Further, the N-Aβ fragment and its core sequence, the N-amyloid-beta core hexapeptide (N-Aβcore), protect against oAβ1-42-associated synapto- and neurotoxicity. Here, we investigated how oAβ1-42, the N-Aβ fragment, and the N-Aβcore regulate the single-channel properties of α7- and α7β2-nicotinic receptors.
Experimental Approach
Single-channel recordings measured the impact of acetylcholine, oAβ1-42, the N-Aβ fragment, and the N-Aβcore on the unitary properties of human α7- and α7β2-containing nicotinic receptors expressed in nicotinic-null SH-EP1 cells. Molecular dynamics simulations identified potential sites of interaction between the N-Aβ fragment and orthosteric α7+/α7- and α7+/β2- nicotinic receptor binding interfaces.
Key Results
The N-Aβ fragment and N-Aβcore induced α7- and α7β2-nicotinic receptor single-channel openings. Relative to acetylcholine, oAβ1-42 preferentially enhanced α7β2-nicotinic receptor single-channel open probability and open-dwell times. Co-application with the N-Aβcore neutralized these effects. Further, administration of the N-Aβ fragment alone, or in combination with acetylcholine or oAβ1-42, selectively enhanced α7-nicotinic receptor open probability and open-dwell times (compared to acetylcholine or oAβ1-42).
Conclusions and Implications
Amyloid-beta peptides demonstrate functional diversity in regulating α7- and α7β2-nicotinic receptor function, with implications for a wide range of nicotinic receptor-mediated functions in Alzheimer's disease. The effects of these peptides on α7- and/or α7β2-nicotinic receptors revealed complex interactions with these subtypes, providing novel insights into the neuroprotective actions of amyloid β-derived fragments against the toxic effects of oAβ1-42.
References
2. 7)Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018). The amyloid-beta oligomer hypothesis: Beginning of the third decade.Journal ofAlzheimer's Disease,64(s1), S567–S610.https://doi.org/10.3233/JAD-179941Curtis, M. J., 8)Alexander, S. P. H., Cirino, G., George, C. H., Kendall, D. A.,Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Patel, H. H., Sobey, C. G.,Stanford, S. C., Stanley, P., Stefanska, B., Stephens, G. J.,Teixeira, M. M., Vergnolle, N., & Ahluwalia, A. (2022). Planning experi-ments: Updated guidance on experimental design and analysis andtheir reporting III.British Journal of Pharmacology,179, 3907–3913.https://doi.org/10.1111/bph.15868Dineley, K. T., Bell, K. 9)A., Bui, D., & Sweatt, J. D. (2002).β-amyloid peptideactivatesα7 nicotinic acetylcholine receptors expressed inXenopusoocytes.The Journal of Biological Chemistry,277(28), 25056–25061.https://doi.org/10.1074/jbc.M200066200.